DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24 | -99.9% | 90 | 0.0% | 0.01% | -12.5% |
Q3 2022 | $23,000 | -61.0% | 90 | -60.9% | 0.01% | -55.6% |
Q2 2022 | $59,000 | -11.9% | 230 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $67,000 | -11.8% | 230 | 0.0% | 0.02% | -10.0% |
Q4 2021 | $76,000 | +8.6% | 230 | 0.0% | 0.02% | 0.0% |
Q3 2021 | $70,000 | +12.9% | 230 | 0.0% | 0.02% | +11.1% |
Q2 2021 | $62,000 | +93.8% | 230 | +64.3% | 0.02% | +63.6% |
Q1 2021 | $32,000 | +3.2% | 140 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $31,000 | +3.3% | 140 | 0.0% | 0.01% | -7.7% |
Q3 2020 | $30,000 | +20.0% | 140 | 0.0% | 0.01% | +8.3% |
Q2 2020 | $25,000 | +31.6% | 140 | 0.0% | 0.01% | +9.1% |
Q1 2020 | $19,000 | -9.5% | 140 | 0.0% | 0.01% | +10.0% |
Q4 2019 | $21,000 | +5.0% | 140 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $20,000 | 0.0% | 140 | 0.0% | 0.01% | -9.1% |
Q2 2019 | $20,000 | +11.1% | 140 | 0.0% | 0.01% | +10.0% |
Q1 2019 | $18,000 | +28.6% | 140 | 0.0% | 0.01% | +11.1% |
Q4 2018 | $14,000 | -6.7% | 140 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $15,000 | +7.1% | 140 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $14,000 | 0.0% | 140 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $14,000 | +7.7% | 140 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $13,000 | +8.3% | 140 | 0.0% | 0.01% | +12.5% |
Q3 2017 | $12,000 | 0.0% | 140 | 0.0% | 0.01% | -11.1% |
Q2 2017 | $12,000 | 0.0% | 140 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $12,000 | +9.1% | 140 | 0.0% | 0.01% | +12.5% |
Q4 2016 | $11,000 | 0.0% | 140 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $11,000 | -21.4% | 140 | 0.0% | 0.01% | -27.3% |
Q2 2016 | $14,000 | +7.7% | 140 | 0.0% | 0.01% | +10.0% |
Q1 2016 | $13,000 | 0.0% | 140 | 0.0% | 0.01% | -9.1% |
Q4 2015 | $13,000 | – | 140 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |